For many purposes the most useful transplantable tumour models for human cancer are spontaneous tumours, non-immunogenic in their original host strain, whose cells are also capable of growth in vitro. The necessity for spontaneous origin and demonstrable non-immunogenicity results from the misleading conclusions which may be drawn from experiments using "induced" immunogenic tumours which may be relatively poor models of cancer in man (Hewitt et al., 1976; Hewitt, 1978) .
It is evident that special value attaches to transplantable experimental tumours which are also capable of culture in vitro, so allowing a range of clinically relevant studies to be carried out. Though many of these in vitro-in vivo tumour systems have been described (Rockwell, 1980) , surprisingly few are of spontaneous origin and known to be nonimmunogenic. Of experimental tumours in common use, only the RIF-l tumour (Twentyman et al., 1980) qualifies in each of these respects. Evidently there exists a need for further spontaneous nonimmunogenic tumours capable of growth in vitro, to widen the spectrum of putative models of human cancer.
In this paper, we describe a new tumour system which fulfils the criteria outlined above. This tumour originated in 1968 when it arose spontaneously in a 13 month old retired breeder female mouse of the C57B-/Icrfa+ ("Black and Tan") strain. The tumour comprised a very firm mass involving the thigh and apparently composed of cartilage and bony protuberances. Histological studies identified the tumour as an osteosarcoma, with newly formed bone, osteoid and cartilage and with two main cell types, one resembling a normal osteoblast and one a fibroblast (see Franks et al., 1973 ; the tumour described here was designated as In earlier studies using this tumour (Franks et al., 1973) , serial transplantation was carried out by implantation of tumour fragments. In the present series of experiments, however, the tumour was disaggregated enzymatically following excisions (3 h incubation at 37°C with collagenase, 2mg ml -') and transplantation achieved by inoculation of a small quantity of cell suspension into the gastronemius muscle of either hind limb. Tumours grew from such inoculation with a somewhat variable latent period which was, however, rarely longer than 2 months at the smallest inoculation size. In the macroscopic growth phase, the tumour was found to be relatively slowly growing for a murine neoplasm with a doubling time of -5 days for the smallest measurable tumour (-5 mm diam.) co The Macmillan Press Ltd., 1985 lengthening to -11-12 days for tumours with a diameter of 8-10mm (see Figure 2) .
In order to assess immunogenicity, a simple TD-50 test was carried out. Though this is not the most ngorous procedure possible, the majority of experimental tumours in common use fail this test (Hewitt, 1978) which constitutes a minimal criterion for absence of immunogenicity. Mice were allocated randomly to one of two groups (-30 Colquhoun (1971) ). TD50 values are not significantly different. Hence, the tumour is "non-immunogenic" as judged by this criterion.
; = ---BIOLOGICAL PROPERTIES OF A SPONTANEOUS MURINE TUMOUR (STS)
Experiments were also carried out to assess the ability of disaggregated tumour cells to grow in vitro. These cells were seeded into 80 cm2 "Nunclon" flasks (Gibco) containing 30 ml full medium and incubated at 37°C in a humidified atmosphere at 5% CO2 in air. The medium was composed of Eagle's minimum essential medium with sodium bicarbonate (Gibco) supplemented with 15% foetal calf serum (Gibco) and antibiotics (penicillin 500 u ml -1, streptomycin 0.5 mgml -1). The Nevertheless, the paucity of in vitro-in vivo systems possessing the desirable features described make it probable that STS can be considered a useful addition to the group of experimental tumours with which in vitro studies can be performed, and which conform to minimal criteria for suitability as models of human cancer.
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